
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.1 | 3.58189514816 | 30.71 | 36.38 | 30.1183 | 1505578 | 32.02606949 | CS |
4 | 0.05 | 0.157430730479 | 31.76 | 36.38 | 27.6427 | 1330152 | 30.62802939 | CS |
12 | 0.91 | 2.94498381877 | 30.9 | 36.38 | 26.74 | 1337209 | 30.97165854 | CS |
26 | -13.76 | -30.195303928 | 45.57 | 56 | 26.74 | 1295677 | 37.26234667 | CS |
52 | 8.25 | 35.0169779287 | 23.56 | 56 | 21.56 | 1305112 | 36.78516792 | CS |
156 | 13.53 | 74.0153172867 | 18.28 | 56 | 4.825 | 1105393 | 22.98801902 | CS |
260 | 5.31 | 20.0377358491 | 26.5 | 56 | 4.825 | 795303 | 23.13815454 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions